How much is Twist Bioscience worth in 2026?

Twist Bioscience has a current valuation of N/A based on their Later Stage VC (Series D) round and secondary market data.

How much funding has Twist Bioscience raised?

Twist Bioscience has raised N/A in total funding across 1 funding rounds.

Twist Bioscience

Drug Discovery

Twist Bioscience valuation and funding history | Last updated: April 2, 2018 | 1 funding rounds

Current Valuation

N/A

As of April 2, 2018

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series D)

$125.0M

Last Funding

Apr 2018

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 2, 2018	Later Stage VC (Series D)	$125.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Twist Bioscience is currently valued at N/A as of April 2, 2018.

Track Twist Bioscience Valuation Updates

Get notified when Twist Bioscience raises new funding or valuation changes

Explore More Data

Detailed analysis for Twist Bioscience

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Twist Bioscience's valuation history, funding rounds, and growth metrics.

No credit card required

What is Twist Bioscience Worth in 2026?

Twist Bioscience is a leading private company in the Drug Discovery sector. Track Twist Bioscience's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Twist Bioscience Valuation is Determined

Private company valuations like Twist Bioscience's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.